Adagio Medical Holder Converts $776,111 of 13% Notes Into 4,978,869 Shares

Adagio Medical Holdings, Inc.

A holder converted $776,111 aggregate principal of Adagio Medical's 13% Senior Secured Convertible Notes between September 25 and October 1, 2026.
The conversion issued 4,978,869 shares of Common Stock at Alternate Conversion Prices ranging from $0.1265 to $0.1618 per share.
Adagio had lowered the Notes' Conversion Price from September 23 through October 31, 2026 to the Alternate Conversion Price in effect on each conversion date.
Shares were issued under the Section 3(a)(9) exemption, with no commission or other remuneration paid for soliciting the exchange.
The 8-K was signed by Deborah Kaster, Chief Financial Officer and Chief Business Officer, and dated October 1, 2026.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.